Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

What is the clinically relevant change on the ADAS-Cog?

Schrag A, Schott JM; Alzheimer's Disease Neuroimaging Initiative.

J Neurol Neurosurg Psychiatry. 2012 Feb;83(2):171-3. doi: 10.1136/jnnp-2011-300881. Epub 2011 Oct 21.

PMID:
22019547
2.

Galantamine for Alzheimer's disease and mild cognitive impairment.

Loy C, Schneider L.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD001747. Review.

PMID:
16437436
3.

Galantamine for Alzheimer's disease.

Olin J, Schneider L.

Cochrane Database Syst Rev. 2001;(4):CD001747. Review. Update in: Cochrane Database Syst Rev. 2002;(3):CD001747.

PMID:
11687119
4.

Galantamine for Alzheimer's disease.

Olin J, Schneider L.

Cochrane Database Syst Rev. 2002;(3):CD001747. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD001747.

PMID:
12137632
5.

Galantamine for Alzheimer's disease.

Loy C, Schneider L.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD001747. Review. Update in: Cochrane Database Syst Rev. 2006;(1):CD001747.

PMID:
15495017
6.

Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task Force [Internet].

Lin JS, O'Connor E, Rossom RC, Perdue LA, Burda BU, Thompson M, Eckstrom E.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Nov.

7.

Cholinesterase inhibitors for rarer dementias associated with neurological conditions.

Li Y, Hai S, Zhou Y, Dong BR.

Cochrane Database Syst Rev. 2015 Mar 3;(3):CD009444. doi: 10.1002/14651858.CD009444.pub3. Review.

PMID:
25734590
8.

Galantamine for vascular cognitive impairment.

Craig D, Birks J.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004746. Review. Update in: Cochrane Database Syst Rev. 2013;4:CD004746.

PMID:
16437493
9.

Donepezil for dementia due to Alzheimer's disease.

Birks J, Harvey RJ.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD001190. Review.

PMID:
16437430
10.

Cholinesterase inhibitors for Alzheimer's disease.

Birks J.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005593. Review.

PMID:
16437532
11.
12.

Metal protein attenuating compounds for the treatment of Alzheimer's dementia.

Sampson EL, Jenagaratnam L, McShane R.

Cochrane Database Syst Rev. 2014 Feb 21;(2):CD005380. doi: 10.1002/14651858.CD005380.pub5. Review.

PMID:
24563468
13.

Donepezil for dementia due to Alzheimer's disease.

Birks JS, Harvey R.

Cochrane Database Syst Rev. 2003;(3):CD001190. Review. Update in: Cochrane Database Syst Rev. 2006;(1):CD001190.

PMID:
12917900
14.

Metal protein attenuating compounds for the treatment of Alzheimer's dementia.

Sampson EL, Jenagaratnam L, McShane R.

Cochrane Database Syst Rev. 2012 May 16;(5):CD005380. doi: 10.1002/14651858.CD005380.pub4. Review. Update in: Cochrane Database Syst Rev. 2014;(2):CD005380.

15.

Galantamine for Alzheimer's disease.

Olin J, Schneider L.

Cochrane Database Syst Rev. 2001;(1):CD001747. Review. Update in: Cochrane Database Syst Rev. 2001;(4):CD001747.

PMID:
11279727
16.

Measuring cognitive change in Alzheimer's disease clinical drug trials.

Harrison JE.

J Nutr Health Aging. 2007 Jul-Aug;11(4):327-9. Review.

PMID:
17653492
17.

Do cognitive interventions improve general cognition in dementia? A meta-analysis and meta-regression.

Huntley JD, Gould RL, Liu K, Smith M, Howard RJ.

BMJ Open. 2015 Apr 2;5(4):e005247. doi: 10.1136/bmjopen-2014-005247. Review. Erratum in: BMJ Open. 2017 Aug 30;7(8):e005247corr1.

Supplemental Content

Support Center